TY - JOUR T1 - Clinical Significance of Past History of Breast Cancer Screening for the Prognosis of Triple Negative Breast Cancer JF - Anticancer Research JO - Anticancer Res SP - 1077 LP - 1082 DO - 10.21873/anticanres.14865 VL - 41 IS - 2 AU - SHINGO INOUE AU - HIROMICHI KAWAIDA AU - RYO SAITO AU - YUKO NAKAYAMA AU - MASATO OHMORI AU - AYAKO KIMURA AU - KATSUTOSHI SHODA AU - SHINJI FURUYA AU - NAOHIRO HOSOMURA AU - HIDENORI AKAIKE AU - YOSHIHIKO KAWAGUCHI AU - HIDETAKE AMEMIYA AU - MAKOTO SUDO AU - HIROSHI KONO AU - DAISUKE ICHIKAWA Y1 - 2021/02/01 UR - http://ar.iiarjournals.org/content/41/2/1077.abstract N2 - Background/Aim: This study examined the prognostic impact of the past history of breast cancer screening within the last 2 years (PH-BCS), for patients with triple negative breast cancer (TNBC), a subtype that carries extremely poor prognosis. Patients and Methods: Eighty-six consecutive cases with TNBC, who underwent surgery at our faculty from 2009 to 2015, were divided into two groups according to PH-BCS. Prognostic analyses for disease-free survival and overall survival between the two groups were performed. Results: The positive PH-BCS group (n=44) had a significantly better prognoses than the negative PH-BCS group (n=42) (p<0.001). No recurrent cases were observed in the positive PH-BCS group. In the negative PH-BCS group, tumor and node status and chemotherapy were indicated as significant prognostic factors, and further step-wise multivariate analysis revealed only node status as a significant prognostic factor. Conclusion: Breast cancer screening at least every 2 years may improve the prognosis of TNBC. ER -